
Bit.bio has announced its cell therapy pipeline as well as having shared its lead cell therapy candidate, preparing to enter …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

